ArticleIDCases2026
Epstein-Barr virus encephalitis in an immunocompetent elderly patient: A case report.
Article in IDCases, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We report a case of severe Epstein-Barr virus (EBV) encephalitis in a 79-year-old immunocompetent patient. The patient initially presented without overt infectious manifestations, complaining solely of weakness in both lower limbs for one week. Physical examination revealed tremors in the upper limbs and tachypnea. Symptoms progressed rapidly after admission, with the subsequent development of headache and fever. Based on the clinical presentation, viral encephalitis was suspected. Cerebrospinal fluid analysis via next-generation sequencing (NGS) confirmed the diagnosis of EBV encephalitis. Despite treatment with ganciclovir, the patient's condition deteriorated, leading to respiratory arrest that required tracheal intubation and mechanical ventilation. The patient's status improved significantly following a combination therapy of intravenous immunoglobulin and steroid pulse therapy, ultimately achieving clinical recovery and successful discharge. This case highlights that EBV encephalitis can occur in immunocompetent elderly individuals, and early-stage symptoms may be atypical. When conventional antiviral therapy proves ineffective, immunoglobulins and corticosteroids should be considered as therapeutic options.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.